Ajanta Pharma Limited

Ajanta Pharma Ltd is a vertically integrated pharmaceutical company headquartered in Mumbai, India. Established in 1973, the company is engaged in the development, manufacturing, and marketing of quality finished dosages, with a strong focus on branded generics. Ajanta Pharma caters to both regulated and emerging markets, supplying prescription products in therapeutic areas such as cardiology, ophthalmology, dermatology, gastroenterology, and pain management. The company has a significant presence across Asia, Africa, the Middle East, and select regulated markets including the United States.

With an extensive product portfolio and a robust international footprint, Ajanta Pharma operates multiple state-of-the-art manufacturing and R&D facilities approved by global regulatory agencies such as the US FDA, WHO-GMP, and UK MHRA. The company's operational model emphasizes backward integration and a focused approach toward high-growth specialty segments, enabling it to deliver sustainable business performance and enter new geographies.